March 11, 2024
Company name:
Repres entativ e:

A l i v e x i s , I n c .
S. Roy Kimura, Ph.D., CEO

Modulus Discovery, Inc. to Change Its Name to Alivexis, Inc.
on March 11, 2024
Modulus Discovery, Inc (Headquartered in Chiyoda-ku, Tokyo; CEO S. Roy Kimura)is pleased to announce that, effective March 11, 2024, the Company has changed its
name to Alivexis, Inc.
【Details】
 New company name: Alivexis, Inc.（URL：https://alivexis.com）
 Date of change: March 11, 2024
*Please note that this change is limited to the company name; there will be no changes
to the address or representatives.
*Concurrent with this name change, our subsidiary, Modulus Discovery, Inc.
(Headquarters: 1 Broadway, 14th Floor, Cambridge, MA 02142; CEO S. Roy Kimura),
will also be changing its name to Alivexis, Inc.
【Purpose of the Company Name Change】
Since its establishment in August 2016, we have committed to delivering groundbreaking
pharmaceuticals efficiently to patients suffering from cancer, chronic immune andinflammatory diseases, and rare diseases, along with their families. Our mission has
been to integrate insights into core biology, cutting-edge drug discovery platforms, anda global network-based research system to advance our unique portfolio of small
molecule drug discovery projects and various research and development collaborations.
Aiming to fulfill this social mission, we have been operating as a network-based drug
discovery company, led by a team with extensive experience in drug discovery andcomputational science research within pharmaceutical and biotechnology companies,
with bases in Tokyo and Boston.
As of March 2024, our strengths - (1) insights into core biology crucial to life and diseases,(2) a unique drug discovery platform, and (3) an attractive drug research pipeline - havebeen crystalized as clinical development candidates in three lead projects, with several
more projects making significant progress into late-stage of lead optimization.
Considering the substantial changes in the internal and external business environment
since the company's inception, we have changed the name of our company and its
subsidiaries to "Alivexis" with the aim of further clarifying our social mission and focus
areas for future business development.
1【Origin of the new Company Name】
The new name "Alivexis" is a blend of "alive," signifying "life, living," "synthesis,"
representing "the combination of various elements to form a larger entity or concept,"and "exis," meaning "to arise, to emerge." It was selected to reflect our hope that vibrant,
healthy, and happy lives will emerge from our drug discovery platform and research anddevelopment activities.
【Our Mission Reinforced by Our New Identity】
Alivexis is dedicated to fostering healthier and more fulfilling lives by integrating cuttingedge drug discovery platforms, profound understanding of disease biology, and agile
global business operations.
【CEO S. Roy Kimura’s Comments】“I am thrilled to announce our new corporate name, Alivexis, which signifies the vitalityof life emerging from our deep commitment and passion to deliver much needed
medicines for patients and their families afflicted by various diseases. Over the last 6years I have had the pleasure to be part of an exceptionally hard-working and talented
team to accomplish what some initially thought impossible -- rapidly discovering multiple
novel high-value drug candidates starting from zero resources by leveraging our cuttingedge drug discovery platform. Our new name marks the beginning of the next stage in
our evolution, growing from a platform-based drug discovery firm to a therapeutics driven
company with a powerful platform and multiple programs nearing clinical trials. We
continue to be excited about our mission to discover and deliver new medicines forpatients in need around the globe.

About the Company
Name： Alivexis, Inc.
Address：Daiichi Hibiya Building 7F Shimbashi 1-18-21, Minato-ku,Tokyo 105-0004
S. Roy Kimura, Ph.D., CEO / Kazuki Ohno, Dr. Eng. COO
Established: August 8, 2016
URL：https://alivexis.com
Business Description: A network-based drug discovery company utilizing cutting-edge
technologies.

Questions?
info@alivexis.com

2